Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Hiroko Okura, Kazuhiko Matsuzawa, et al. Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report. Diabetology & Metabolic Syndrome. 2022. 14. 1
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, et al. The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes. Scientific Reports. 2022. 12. 1
Tsuyoshi Okura, Kei Teramoto, Rie Koshitani, Sonoko Kawamoto, Yuichi Ito, Yohei Fujioka, Keisuke Sumi, Kyoko Shoji, Risa Nakamura, Kazuhisa Matsumoto, et al. The Glucose Monitoring System Reduces the Incidents of Glucose Measurement. DIABETES. 2017. 66. A237-A237
Tsuyoshi Okura, Youhei Fujioka, Risa Nakanishi, Hideki Shiochi, Keisuke Sumi, Kyoko Shoji, Ayumi Murawaki, Kazuhiko Matsuzawa, Schoichiro Izawa, Chieko Sakai, et al. 20/(Fasting C-Peptide x Fasting Plasma Glucose) Is a Novel Index of Insulin Resistance with Small Effect of Hepatic Insulin Clearance. DIABETES. 2015. 64. A496-A496
Y. Fujioka, T. Ohkura, K. Shoji, K. Sumi, H. Shiochi, N. Yamamoto, K. Matsuzawa, A. Murawaki, S. Izawa, H. Ohkura, et al. Normal meal tolerance test is more valuable than glucagon stimulation test in type 2 diabetes. DIABETOLOGIA. 2014. 57. S210-S210